169 related articles for article (PubMed ID: 21920691)
21. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
22. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
[TBL] [Abstract][Full Text] [Related]
23. Budesonide/cyclodextrin complex-loaded lyophilized microparticles for intranasal application.
Kim JE; Cho HJ; Kim DD
Drug Dev Ind Pharm; 2014 Jun; 40(6):743-8. PubMed ID: 23547762
[TBL] [Abstract][Full Text] [Related]
24. Solid state characterization of azelnidipine-oxalic acid co-crystal and co-amorphous complexes: The effect of different azelnidipine polymorphs.
Pan Y; Pang W; Lv J; Wang J; Yang C; Guo W
J Pharm Biomed Anal; 2017 May; 138():302-315. PubMed ID: 28237872
[TBL] [Abstract][Full Text] [Related]
25. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
26. Physical-chemical characterization of binary systems of metformin hydrochloride with triacetyl-beta-cyclodextrin.
Corti G; Capasso G; Maestrelli F; Cirri M; Mura P
J Pharm Biomed Anal; 2007 Nov; 45(3):480-6. PubMed ID: 17822867
[TBL] [Abstract][Full Text] [Related]
27. Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies.
Shende PK; Gaud RS; Bakal R; Patil D
Colloids Surf B Biointerfaces; 2015 Dec; 136():105-10. PubMed ID: 26364091
[TBL] [Abstract][Full Text] [Related]
28. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
29. insights into novel supramolecular complexes of two solid forms of norfloxacin and β-cyclodextrin.
Chattah AK; Mroue KH; Pfund LY; Ramamoorthy A; Longhi MR; Garnero C
J Pharm Sci; 2013 Oct; 102(10):3717-24. PubMed ID: 23904189
[TBL] [Abstract][Full Text] [Related]
30. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
32. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
33. Development of carvedilol-cyclodextrin inclusion complexes using fluid-bed granulation: a novel solid-state complexation alternative with technological advantages.
Alonso EC; Riccomini K; Silva LA; Galter D; Lima EM; Durig T; Taveira SF; Martins FT; Cunha-Filho MS; Marreto RN
J Pharm Pharmacol; 2016 Oct; 68(10):1299-309. PubMed ID: 27465985
[TBL] [Abstract][Full Text] [Related]
34. Complex of rutin with β-cyclodextrin as potential delivery system.
Paczkowska M; Mizera M; Piotrowska H; Szymanowska-Powałowska D; Lewandowska K; Goscianska J; Pietrzak R; Bednarski W; Majka Z; Cielecka-Piontek J
PLoS One; 2015; 10(3):e0120858. PubMed ID: 25822535
[TBL] [Abstract][Full Text] [Related]
35. Effects of cogrinding with β-cyclodextrin on the solid state fentanyl.
Ogawa N; Higashi K; Nagase H; Endo T; Moribe K; Loftsson T; Yamamoto K; Ueda H
J Pharm Sci; 2010 Dec; 99(12):5019-29. PubMed ID: 20821388
[TBL] [Abstract][Full Text] [Related]
36. Influence of cyclodextrin complexation on piroxicam gel formulations.
Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B
Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834
[TBL] [Abstract][Full Text] [Related]
37. Analysis of the complexation of gemfibrozil with gamma- and hydroxypropyl-gamma-cyclodextrins.
Fernández L; Martínez-Ohárriz MC; Martín C; Vélaz I; Sánchez M; Zornoza A
J Pharm Biomed Anal; 2008 Aug; 47(4-5):943-8. PubMed ID: 18423939
[TBL] [Abstract][Full Text] [Related]
38. Inclusion complex of trimethoprim with beta-cyclodextrin.
Li N; Zhang YH; Wu YN; Xiong XL; Zhang YH
J Pharm Biomed Anal; 2005 Sep; 39(3-4):824-9. PubMed ID: 16011886
[TBL] [Abstract][Full Text] [Related]
39. Physical properties of the complexes formed between heptakis(2,6-di-O-methyl)-beta-cyclodextrin, beta-cyclodextrin, and chlorambucil.
Green AR; Miller ES; Guillory JK
J Pharm Sci; 1991 Feb; 80(2):186-9. PubMed ID: 2051328
[TBL] [Abstract][Full Text] [Related]
40. Preparation, characterization and in vivo evaluation of formulation of baicalein with hydroxypropyl-beta-cyclodextrin.
Liu J; Qiu L; Gao J; Jin Y
Int J Pharm; 2006 Apr; 312(1-2):137-43. PubMed ID: 16459034
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]